Doctors have an overwhelming amount of individual patient data and medical research at their disposal to make diagnoses and ...
This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...
Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of ...
Preparing cancer patients for difficult decisions is an oncologist's job. They don't always remember to do it, however.
A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Leading private capital deals today include Blackstone's $300 million investment in DDN and a B Capital-led $275 million ...
Hippocratic AI, a startup building AI solutions that can handle non-diagnostic patient-facing tasks, secured a massive $141 ...
Healthcare AI company Innovaccer closed a $275 million Series F funding round, bringing its fundraising total to date to $675 ...
Nearly 30% of the funding poured into healthcare startups last year, including for biotechs, went to companies leveraging ...
AI can compare thousands of images to uncover dangerous patterns, create ultra-high resolution scans from low-res images and ...
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...